Cargando…

Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis

BACKGROUND: Lung macrophages are major participants in the pulmonary innate immune response. In the cystic fibrosis (CF) lung, the inability of lung macrophages to successfully regulate the exaggerated inflammatory response suggests dysfunctional innate immune cell function. In this study, we aim to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Youdinghuan, Armstrong, David A., Salas, Lucas A., Hazlett, Haley F., Nymon, Amanda B., Dessaint, John A., Aridgides, Daniel S., Mellinger, Diane L., Liu, Xiaoying, Christensen, Brock C., Ashare, Alix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288922/
https://www.ncbi.nlm.nih.gov/pubmed/30526669
http://dx.doi.org/10.1186/s13148-018-0580-2
_version_ 1783379886821343232
author Chen, Youdinghuan
Armstrong, David A.
Salas, Lucas A.
Hazlett, Haley F.
Nymon, Amanda B.
Dessaint, John A.
Aridgides, Daniel S.
Mellinger, Diane L.
Liu, Xiaoying
Christensen, Brock C.
Ashare, Alix
author_facet Chen, Youdinghuan
Armstrong, David A.
Salas, Lucas A.
Hazlett, Haley F.
Nymon, Amanda B.
Dessaint, John A.
Aridgides, Daniel S.
Mellinger, Diane L.
Liu, Xiaoying
Christensen, Brock C.
Ashare, Alix
author_sort Chen, Youdinghuan
collection PubMed
description BACKGROUND: Lung macrophages are major participants in the pulmonary innate immune response. In the cystic fibrosis (CF) lung, the inability of lung macrophages to successfully regulate the exaggerated inflammatory response suggests dysfunctional innate immune cell function. In this study, we aim to gain insight into innate immune cell dysfunction in CF by investigating alterations in DNA methylation in bronchoalveolar lavage (BAL) cells, composed primarily of lung macrophages of CF subjects compared with healthy controls. All analyses were performed using primary alveolar macrophages from human subjects collected via bronchoalveolar lavage. Epigenome-wide DNA methylation was examined via Illumina MethylationEPIC (850 K) array. Targeted next-generation bisulfite sequencing was used to validate selected differentially methylated CpGs. Methylation-based sample classification was performed using the recursively partitioned mixture model (RPMM) and was tested against sample case-control status. Differentially methylated loci were identified by fitting linear models with adjustment of age, sex, estimated cell type proportions, and repeat measurement. RESULTS: RPMM class membership was significantly associated with the CF disease status (P = 0.026). One hundred nine CpG loci were differentially methylated in CF BAL cells (all FDR ≤ 0.1). The majority of differentially methylated loci in CF were hypo-methylated and found within non-promoter CpG islands as well as in putative enhancer regions and DNase hyper-sensitive regions. CONCLUSIONS: These results support a hypothesis that epigenetic changes, specifically DNA methylation at a multitude of gene loci in lung macrophages, may participate, at least in part, in driving dysfunctional innate immune cells in the CF lung. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-018-0580-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6288922
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62889222018-12-14 Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis Chen, Youdinghuan Armstrong, David A. Salas, Lucas A. Hazlett, Haley F. Nymon, Amanda B. Dessaint, John A. Aridgides, Daniel S. Mellinger, Diane L. Liu, Xiaoying Christensen, Brock C. Ashare, Alix Clin Epigenetics Research BACKGROUND: Lung macrophages are major participants in the pulmonary innate immune response. In the cystic fibrosis (CF) lung, the inability of lung macrophages to successfully regulate the exaggerated inflammatory response suggests dysfunctional innate immune cell function. In this study, we aim to gain insight into innate immune cell dysfunction in CF by investigating alterations in DNA methylation in bronchoalveolar lavage (BAL) cells, composed primarily of lung macrophages of CF subjects compared with healthy controls. All analyses were performed using primary alveolar macrophages from human subjects collected via bronchoalveolar lavage. Epigenome-wide DNA methylation was examined via Illumina MethylationEPIC (850 K) array. Targeted next-generation bisulfite sequencing was used to validate selected differentially methylated CpGs. Methylation-based sample classification was performed using the recursively partitioned mixture model (RPMM) and was tested against sample case-control status. Differentially methylated loci were identified by fitting linear models with adjustment of age, sex, estimated cell type proportions, and repeat measurement. RESULTS: RPMM class membership was significantly associated with the CF disease status (P = 0.026). One hundred nine CpG loci were differentially methylated in CF BAL cells (all FDR ≤ 0.1). The majority of differentially methylated loci in CF were hypo-methylated and found within non-promoter CpG islands as well as in putative enhancer regions and DNase hyper-sensitive regions. CONCLUSIONS: These results support a hypothesis that epigenetic changes, specifically DNA methylation at a multitude of gene loci in lung macrophages, may participate, at least in part, in driving dysfunctional innate immune cells in the CF lung. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-018-0580-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-12-10 /pmc/articles/PMC6288922/ /pubmed/30526669 http://dx.doi.org/10.1186/s13148-018-0580-2 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Chen, Youdinghuan
Armstrong, David A.
Salas, Lucas A.
Hazlett, Haley F.
Nymon, Amanda B.
Dessaint, John A.
Aridgides, Daniel S.
Mellinger, Diane L.
Liu, Xiaoying
Christensen, Brock C.
Ashare, Alix
Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis
title Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis
title_full Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis
title_fullStr Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis
title_full_unstemmed Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis
title_short Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis
title_sort genome-wide dna methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288922/
https://www.ncbi.nlm.nih.gov/pubmed/30526669
http://dx.doi.org/10.1186/s13148-018-0580-2
work_keys_str_mv AT chenyoudinghuan genomewidednamethylationprofilingshowsadistinctepigeneticsignatureassociatedwithlungmacrophagesincysticfibrosis
AT armstrongdavida genomewidednamethylationprofilingshowsadistinctepigeneticsignatureassociatedwithlungmacrophagesincysticfibrosis
AT salaslucasa genomewidednamethylationprofilingshowsadistinctepigeneticsignatureassociatedwithlungmacrophagesincysticfibrosis
AT hazletthaleyf genomewidednamethylationprofilingshowsadistinctepigeneticsignatureassociatedwithlungmacrophagesincysticfibrosis
AT nymonamandab genomewidednamethylationprofilingshowsadistinctepigeneticsignatureassociatedwithlungmacrophagesincysticfibrosis
AT dessaintjohna genomewidednamethylationprofilingshowsadistinctepigeneticsignatureassociatedwithlungmacrophagesincysticfibrosis
AT aridgidesdaniels genomewidednamethylationprofilingshowsadistinctepigeneticsignatureassociatedwithlungmacrophagesincysticfibrosis
AT mellingerdianel genomewidednamethylationprofilingshowsadistinctepigeneticsignatureassociatedwithlungmacrophagesincysticfibrosis
AT liuxiaoying genomewidednamethylationprofilingshowsadistinctepigeneticsignatureassociatedwithlungmacrophagesincysticfibrosis
AT christensenbrockc genomewidednamethylationprofilingshowsadistinctepigeneticsignatureassociatedwithlungmacrophagesincysticfibrosis
AT asharealix genomewidednamethylationprofilingshowsadistinctepigeneticsignatureassociatedwithlungmacrophagesincysticfibrosis